Wexford Capital »

Avadel Pharmaceuticals shares owned by Wexford Capital

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Wexford Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $723k 92k 7.83

More positions owned by Wexford Capital

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Mammoth Energy Svcs (TUSK)
Nephros (NEPH)
Core Natural Resources Com Shs (CNR)
EQT Corporation (EQT)
Chesapeake Energy Corp (EXE)
Energy Transfer Com Ut Ltd Ptn (ET)
Teekay Tankers Cl A (TNK)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Imperial Pete Com New (IMPP)
Acm Resh Com Cl A (ACMR)
Enterprise Products Partners (EPD)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Century Aluminum Company (CENX)
Antero Res (AR)

View all positions for Wexford Capital

Top funds holding Avadel Pharmaceuticals

Henderson Group
BlackRock
Vanguard Group
Brandes Investment Partners
Two Seas Capital
Jeffrey L. Gendell
Polar Capital Holdings
Vivo Capital
State Street Corporation
Wealth Effects
Geode Capital Management
Tang Capital Management
Susquehanna International
Kennedy Capital Management
Citadel Advisors

View all funds holding Avadel Pharmaceuticals